Regulation

The American Medical Association uses “augmented intelligence,” not “artificial intelligence,” as the tech is meant to support, not replace, people, said Dr. Jesse Ehrenfeld, president of the AMA. Still, new regulatory paradigms are needed.

The kit was determined to be comparable to a device used in clinically-administered intrauterine insemination.

Dr. Michael Howell, Google's chief clinical officer, discusses what federal regulators should consider while configuring rules around AI use in healthcare and how the company ensures health equity within its medically tuned LLM, Med-PaLM.  

Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.

Health systems' cybersecurity infrastructure is only as strong as its weakest third-party vendor, says chief healthcare officer at Ordr Wes Wright, and government should fund cybersecurity because it requires systems to have a digital footprint.

The AI-enabled hearing aids automatically adjust to an individual's hearing needs without configuration.

The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

Dr. Robert Murry, chief medical officer at NextGen Healthcare, talks about the end of pandemic-era telehealth policy changes, how providers have adopted telemedicine following the pandemic and CMS' commitment to telehealth and privacy.